Chaoju Eye Care Holdings Limited
Chaoju Eye Care Holdings Limited (2219.HK) Financial Performance & Income Statement Overview
Review Chaoju Eye Care Holdings Limited (2219.HK) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Chaoju Eye Care Holdings Limited (2219.HK) Income Statement & Financial Overview
Explore comprehensive income reports for Chaoju Eye Care Holdings Limited 2219.HK, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $335.58M | $335.58M | $367.14M | $367.14M |
| Cost of Revenue | $197.92M | $197.92M | $199.16M | $199.16M |
| Gross Profit | $137.66M | $137.66M | $167.99M | $167.99M |
| Gross Profit Ratio | $0.41 | $0.41 | $0.46 | $0.46 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $97.10M | $97.10M | $85.004M | $85.004M |
| Operating Expenses | $97.10M | $97.10M | $85.004M | $85.004M |
| Total Costs & Expenses | $295.02M | $295.02M | $284.16M | $284.16M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $22.11M | $22.11M | $22.03M | $22.03M |
| EBITDA | $62.67M | $62.67M | $105.01M | $105.01M |
| EBITDA Ratio | $0.19 | $0.19 | $0.29 | $0.29 |
| Operating Income | $40.56M | $40.56M | $82.98M | $82.98M |
| Operating Income Ratio | $0.12 | $0.12 | $0.23 | $0.23 |
| Other Income/Expenses (Net) | $980500.00 | $980500.00 | $6.84M | $6.84M |
| Income Before Tax | $41.54M | $41.54M | $89.82M | $89.82M |
| Income Before Tax Ratio | $0.12 | $0.12 | $0.24 | $0.24 |
| Income Tax Expense | $15.25M | $15.25M | $23.01M | $23.01M |
| Net Income | $29.31M | $29.31M | $68.23M | $68.23M |
| Net Income Ratio | $0.09 | $0.09 | $0.19 | $0.19 |
| EPS | $0.04 | $0.04 | $0.10 | $0.10 |
| Diluted EPS | $0.04 | $0.04 | $0.10 | $0.10 |
| Weighted Avg Shares Outstanding | $727.06M | $727.06M | $687.68M | $687.68M |
| Weighted Avg Shares Outstanding (Diluted) | $694.99M | $694.99M | $687.68M | $687.68M |
Over the last four quarters, Chaoju Eye Care Holdings Limited's revenue moved from $367.14M in Q1 2024 to $335.58M in Q4 2024. Operating income in Q4 2024 was $40.56M, with a strong operating margin of 12%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Chaoju Eye Care Holdings Limited remained robust at $62.67M, reflecting operational efficiency. Net income rose to $29.31M, with an EPS of $0.04. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan